Helios is the world's highest-resolution picture of your body's biology and health, in a blood test you take at home to help you live longer.
We are building what medicine should have been. Not the version that waits for you to break, but one that sees you clearly and early, while everything is still in your hands.
It starts with a single drop of blood, collected at home. We read it across more than 1,000 biomarkers and build it into a living model of your body, one that shows you what is happening inside you now and what is coming next. Not a number on a chart. A picture of you, and it moves.
Our goal is simple to say and enormous to build: simulate all of human health. We are physician-scientists, engineers, and builders working in one room, and we are just getting started. Plenty of people are already excited by what we have made. We are more excited by what is still to come.
We are not doing this alone. We ran our own lab at Harvard, where we researched and published on the proteomics this product uses, and we have started multiple biotech companies that raised over $300 million, with multiple exits. Our seed round is backed by Y Combinator and Formation, with angels spanning medicine, AI, and consumer technology — among them the chief innovation officer of a top Harvard teaching hospital, founders behind landmark digital health and biotech exits, founders and operators from leading AI companies, a Y Combinator partner, and one of tech's most-followed creators.
If that pulls at you, reach out at hello@heliosinc.ai or see open positions.